Brevibacillus laterosporus
At a glance
- Best for
- no established human use; data are preclinical
- Typical dose
- not established for humans
- Time to effect
- Uncertain
- Main caution
- lacks human safety and efficacy data as a probiotic; benefit is unproven
What is it
Brevibacillus laterosporus is a spore-forming soil bacterium that has been investigated as a biocontrol agent and, in some products, marketed as a probiotic. Its proposed activity is producing antimicrobial compounds active against other microbes. There are essentially no controlled human trials, and its use as a human probiotic is not well established or validated for safety.
Is it worth it for you?
Worth considering if…
- you accept that human evidence is essentially absent
Probably skip if…
- you want an evidence-based probiotic (choose well-studied strains)
- you are immunocompromised
- you expect a proven digestive or immune benefit
Evidence at a glance
| Goal | Evidence | Effect | Best fit | Time |
|---|---|---|---|---|
| antimicrobial activity against other microbes | Mixed Evidence | Unknown in humans | not established | Uncertain |
Evidence for 1 use
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
antimicrobial activity against other microbes
Mechanism onlyBrevibacillus laterosporus produces antimicrobial substances and has been studied as a biocontrol agent against insects, fungi, and some bacteria in laboratory and environmental settings. There are no robust human trials demonstrating a probiotic or therapeutic benefit, and its safety as an ingested human probiotic is not well characterized. Any human benefit is purely speculative based on microbial mechanisms.
Bottom line: B. laterosporus has antimicrobial activity in the lab, but there is no credible human evidence supporting its use as a probiotic.
Evidence is mixed
Evidence is confined to in-vitro and biocontrol studies; human efficacy and safety data are absent.
How to take it
- Typical dose
- no validated human dose
- Timing
- as directed by the product
- With food
- as directed
- How long to try
- short trial only, given limited data
What to track
- digestive comfort
- any adverse symptoms
Safety
Common side effects
not characterized in humans
Serious risks
- unknown safety profile as an ingested human probiotic
Who should avoid it
- immunocompromised people
- critically ill people
- people with central venous catheters
Pregnancy & breastfeeding
No human safety data; avoid in pregnancy.
Choosing a product
Look for
- clearly identifies the strain
- discloses CFU count and viability
- third-party verification of identity and purity
Be skeptical of
- treats infections
- restores gut health
- human benefit claims based on biocontrol or lab data
References by claim
Track Brevibacillus laterosporus with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.